About NanoVation Therapeutics
NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. NanoVation’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery).
NanoVation partners with leading pharmaceutical and biotech companies to develop genetic medicines for previously untreatable diseases. NanoVation's toolbox offers a "one-stop-shop" IP portfolio for LNP-based genetic medicine development, with comprehensive solutions spanning novel lipid designs, RNA modifications and LNP compositions.
We are building our team and looking for highly motivated individuals to deliver tomorrow's genetic medicines, today. For more information, please visit nanovationtx.com.
If we do not currently have any career opportunities posted, please provide your resume and contact details for consideration for future opportunities.
Our office Location:
2nd Floor, 2665 East Mall
Vancouver BC V6T 1Z4
Canada
What We Do
NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limits of existing approaches to nucleic acid delivery, including the ability to target tissues outside the liver (extrahepatic delivery). NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNP™) platform, which enables functional nucleic acid delivery to extrahepatic cell types and has demonstrated an improved therapeutic index in preclinical studies. NanoVation partners with leading pharmaceutical and biotech companies to enable the development of genetic medicines for previously untreatable diseases. For additional information, please visit nanovationtx.com
